Founded by a team from Elan plc. AGI focused on the development and commercialisation of differentiated specialty drug products to treat unmet medical needs. The Company completed an IPO in 2006 and was acquired by Vidara Therapeutics in 2012.
ACT Venture Capital Limited (Registered in Ireland, Company Number: 120334). ACT Venture Capital Limited is regulated by the Central Bank of Ireland.
Copyright © ACT Venture Capital 2009-2012.
Visual, Interaction and User Experience Design by